ALK and cancer: Indeed, cancer cells where genomic alterations of ALK lead to expression of truncated variants, such as NSCLC (EML4-ALK) and ALCL (NPM-ALK), are addicted to ALK signalling because translocations provide dimerization domains that render fusion proteins ligand independent.